Viral vectors for the expression of proteins in plants - PubMed (original) (raw)
Review
Viral vectors for the expression of proteins in plants
Yuri Gleba et al. Curr Opin Biotechnol. 2007 Apr.
Abstract
The use of plant viral vectors for the transient expression of heterologous proteins offers a useful tool for the large-scale production of proteins of industrial importance, such as antibodies and vaccine antigens. In recent years, advances have been made both in the development of first-generation vectors (that employ the 'full virus') and second-generation ('deconstructed virus') vectors. For example, vectors based around the 'full virus' strategy can now be used to express long polypeptides (at least 140 amino acids long) as fusions to the coat protein. In addition, a new generation of vectors was engineered to have a reactogenic amino acid exposed on the surface of the virus, allowing easy chemical conjugation of (separately produced) proteins to the viral surface. This approach is being used to develop new vaccines in the form of antigens coupled to a plant viral surface. Prototypes of industrial processes that require high-yield production, rapid scale-up, and fast manufacturing have been recently developed using the 'deconstructed virus' approach (magnifection). This process, which relies on Agrobacterium as a vector to deliver DNA copies of one or more viral RNA replicons to plant cells, has been shown to work with numerous proteins, including full immunoglobulin G antibodies. Other advances in this area have looked at the development of inducible viral systems and the use of viral vectors to produce nanoscale materials for modular assembly.
Similar articles
- Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies.
Gleba Y, Marillonnet S, Klimyuk V. Gleba Y, et al. Curr Opin Plant Biol. 2004 Apr;7(2):182-8. doi: 10.1016/j.pbi.2004.01.003. Curr Opin Plant Biol. 2004. PMID: 15003219 Review. - Magnifection--a new platform for expressing recombinant vaccines in plants.
Gleba Y, Klimyuk V, Marillonnet S. Gleba Y, et al. Vaccine. 2005 Mar 18;23(17-18):2042-8. doi: 10.1016/j.vaccine.2005.01.006. Vaccine. 2005. PMID: 15755568 Review. - Plant viral vectors for delivery by Agrobacterium.
Gleba YY, Tusé D, Giritch A. Gleba YY, et al. Curr Top Microbiol Immunol. 2014;375:155-92. doi: 10.1007/82_2013_352. Curr Top Microbiol Immunol. 2014. PMID: 23949286 Review. - High-yield production of authentic human growth hormone using a plant virus-based expression system.
Gils M, Kandzia R, Marillonnet S, Klimyuk V, Gleba Y. Gils M, et al. Plant Biotechnol J. 2005 Nov;3(6):613-20. doi: 10.1111/j.1467-7652.2005.00154.x. Plant Biotechnol J. 2005. PMID: 17147632 - Infectious full-length clones of plant viruses and their use for construction of viral vectors.
Nagyová A, Subr Z. Nagyová A, et al. Acta Virol. 2007;51(4):223-37. Acta Virol. 2007. PMID: 18197730 Review.
Cited by
- Production of active human iduronate-2-sulfatase (IDS) enzyme in Nicotiana benthamiana.
Sinha MH, Mehtab T, Entesari M, Nguyen HH, Yun A, Hwang I. Sinha MH, et al. Sci Rep. 2024 Oct 4;14(1):23066. doi: 10.1038/s41598-024-73778-x. Sci Rep. 2024. PMID: 39367006 Free PMC article. - Improving transient expression in N. benthamiana by suppression of the Nb-SABP2 and Nb-COI1 plant defence response related genes.
Kopertekh L. Kopertekh L. Front Plant Sci. 2024 Sep 9;15:1453930. doi: 10.3389/fpls.2024.1453930. eCollection 2024. Front Plant Sci. 2024. PMID: 39315373 Free PMC article. - Antimicrobial Peptides: The Production of Novel Peptide-Based Therapeutics in Plant Systems.
Tiwari P, Srivastava Y, Sharma A, Vinayagam R. Tiwari P, et al. Life (Basel). 2023 Sep 7;13(9):1875. doi: 10.3390/life13091875. Life (Basel). 2023. PMID: 37763279 Free PMC article. Review. - The Synergistic Effects of Environmental and Genetic Factors on the Regulation of Anthocyanin Accumulation in Plant Tissues.
Do VG, Lee Y, Kim JH, Kwon YS, Park JT, Yang S, Park J, Win NM, Kim S. Do VG, et al. Int J Mol Sci. 2023 Aug 18;24(16):12946. doi: 10.3390/ijms241612946. Int J Mol Sci. 2023. PMID: 37629128 Free PMC article. - Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant.
Waerlop G, Janssens Y, Jacobs B, Jarczowski F, Diessner A, Leroux-Roels G, Klimyuk V, Leroux-Roels I, Thieme F. Waerlop G, et al. Front Immunol. 2023 Jun 26;14:1188431. doi: 10.3389/fimmu.2023.1188431. eCollection 2023. Front Immunol. 2023. PMID: 37435073 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources